Nanoparticles with two agents reduced cartilage damage in mice
In an animal experiment, cartilage-targeting particles reduced cartilage loss in 18-month-old male mice, with six per group, assessed after two months.
Our read
Interventions- Studied:
- Experiments in 18-month-old male mice, two months, against other nanoparticle formulations
- What changed:
- Cartilage loss was lower with the combined particles than with other nanoparticle formulations in 18-month-old mice
- The catch:
- There were only six mice per group
Editor of record: Boris Djordjevic · AgingResearch.News
An experiment in male C57BL/6 mice tested cartilage-targeting nanoparticles carrying lycopene, an antioxidant, and a small RNA designed to lower production of WTAP, a protein involved in adding chemical marks to RNA.
In 18-month-old mice, with six per group, the combined particles reduced cartilage loss more than other nanoparticle formulations at assessments after two months. They also reduced markers of senescence, a state in which cells stop dividing. The particles also reduced cartilage degeneration in mice with surgically induced osteoarthritis, using 8-week-old males with six per group. Researchers injected the particles into joints. Safety tests at a lycopene-equivalent dose of 2.5 milligrams per kilogram found no apparent major-organ damage after two months or significant blood-count differences after two weeks.
Why it matters
Cartilage-cell senescence is a research target in age-related osteoarthritis. The authors highlight jointly targeting damaging reactive molecules and abnormal chemical marking of RNA as an approach to age-related joint disease.
Caveats
These experiments involved male mice, with six animals per group. They do not establish benefit or safety in people.
The paper
Nanjing Drum Tower Hospital
Bioactive Materials, Jul 31, 2026, Open access
Comments
Be the first to comment.